EGFR activating aberration occurs independently of other genetic aberrations or telomerase activation in adenocarcinoma of the lung

Oncology Reports

Volumn 17, Issue 6, 2007, Pages 1405-1411

  Arifin, Marina ^a   Hiyama, Keiko ^a   Tanimoto, Keiji ^a   Wiyono, Wiwien Heru ^a,b   Hiyama, Eiso ^a   Nishiyama, Masahiko ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

EGFR; Lung adenocarcinoma; RB1; Telomerase; TP53

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KRAS PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN P53; RAS PROTEIN; RETINOBLASTOMA PROTEIN; TELOMERASE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; AGED; ARTICLE; CHROMOSOME ABERRATION; ENZYMOLOGY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE FREQUENCY; GENETICS; HETEROZYGOSITY LOSS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MUTATION;

ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOME ABERRATIONS; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE FREQUENCY; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETINOBLASTOMA PROTEIN; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34548035184     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.6.1405     Document Type: Article

References (30)

1. Minna JD, Roth JA and Gazdar AF: Focus on lung cancer. Cancer Cell 1: 49-52, 2002. (Pubitemid 41039175)
2. Miller YE: Pathogenesis of lung cancer: 100 year report. Am J Respir Cell Mol Biol 33: 216-223, 2005.
3. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA and Shay JW: Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 87: 895-902, 1995.
4. Kawashima T, Kagawa S, Kobayashi N, Shirakiya Y, Umeoka T, Teraishi F, Taki M, Kyo S, Tanaka N and Fujiwara T: Telomerase-specific replication- selective virotherapy for human cancer. Clin Cancer Res 10: 285-292, 2004. (Pubitemid 38114191)
5. Seimiya H, Muramatsu Y, Ohishi T and Tsuruo T: Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics. Cancer Cell 7: 25-37, 2005. (Pubitemid 40126380)
6. Shay JW and Wright WE: Telomerase therapeutics for cancer: challenges and new directions. Nat Rev Drug Discov 5: 577-584, 2006. (Pubitemid 43971192)
7. Miyazu YM, Miyazawa T, Hiyama K, Kurimoto N, Iwamoto Y, Matsuura H, Kanoh K, Kohno N, Nishiyama M and Hiyama E: Telomerase expression in non-cancerous bronchial epithelia is a possible marker of early development of lung cancer. Cancer Res 65: 9623-9627, 2005. (Pubitemid 41541435)
8. Hiyama K, Ishioka S, Shirotani Y, Inai K, Hiyama E, Murakami I, Isobe T, Inamizu T and Yamakido M: Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene 10: 937-944, 1995.
9. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F and Salomon DS: Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366: 2-16, 2006. (Pubitemid 43199589)
10. Pao W and Miller VA: Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions. J Clin Oncol 23: 2556-2568, 2005.
11. Yarden Y and Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127-137, 2001. (Pubitemid 33674041)
12. Olayioye MA, Neve RM, Lane HA and Hynes NE: The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19: 3159-3167, 2000. (Pubitemid 30428195)
13. Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell 103: 211-225, 2000.
14. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW and Burgess AW: Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284: 31-53, 2003. (Pubitemid 36331965)
15. Herbst RS and Shin DM: Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy. Cancer 94: 1593-1611, 2002. (Pubitemid 34212655)
16. Ettinger DS: Clinical implications of EGFR expression in the development and progression of solid tumors: focus on non-small cell lung cancer. Oncologist 11: 358-373, 2006.
17. Janne PA, Engelman JA and Johnson BE: Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology. J Clin Oncol 23: 3227-3234, 2005. (Pubitemid 46211347)
18. Yokoyama T, Kondo M, Goto Y, Fukui T, Yoshioka H, Yokoi K, Osada H, Imaizumi K, Hasegawa Y, Shimokata K and Sekido Y: EGFR point mutation in non-small cell lung cancer is occasionally accompanied by a second mutation or amplification. Cancer Sci 97: 753-759, 2006. (Pubitemid 43983788)
19. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J and Haber DA: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129-2139, 2004. (Pubitemid 38637993)
20. Sordella R, Bell DW, Haber DA and Settleman J: Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 305: 1163-1167, 2004. (Pubitemid 39100331)
21. Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, Mardis E, Kupfer D, Wilson R, Kris M and Varmus H: EGF receptor gene mutations are common in lung cancers from 'never smokers' and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101: 13306-13311, 2004. (Pubitemid 39209661)
22. Bianco R, Troiani T, Tortora G and Ciardiello F: Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy. Endocr Relat Cancer 12 (suppl 1): S159-S171, 2005. (Pubitemid 41395423)
23. Mendoza C, Sato H, Hiyama K, Ishioka S, Isobe T, Maeda H, Hiyama E, Inai K and Yamakido M: Allelotype and loss of heterozygosity around the L-myc gene locus in primary lung cancers. Lung Cancer 28: 117-125, 2000. (Pubitemid 30136411)
24. Tomizawa Y, Iijima H, Sunaga N, Sato K, Takise A, Otani Y, Tanaka S, Suga T, Saito R, Ishizuka T, Dobashi K, Minna JD, Nakajima T and Mori M: Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer. Clin Cancer Res 11: 6816-6822, 2005. (Pubitemid 41428736)
25. Bell DW, Lynch TJ, Haserlat SM, Harris PL, Okimoto RA, Brannigan BW, Sgroi DC, Muir B, Riemenschneider MJ, Iacona RB, Krebs AD, Johnson DH, Giaccone G, Herbst RS, Manegold C, Fukuoka M, Kris MG, Baselga J, Ochs JS and Haber DA: Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials. J Clin Oncol 23: 8081-8092, 2005. (Pubitemid 46657411)
26. Wang G, Brennan C, Rook M, Wolfe JL, Leo C, Chin L, Pan H, Liu WH, Price B and Makrigiorgos GM: Balanced-PCR amplification allows unbiased identification of genomic copy changes in minute cell and tissue samples. Nucleic Acids Res 32: E76, 2004.
27. Amador ML, Oppenheimer D, Perea S, Maitra A, Cusati G, Iacobuzio-Donahue C, Baker SD, Ashfaq R, Takimoto C, Forastiere A and Hidalgo M: An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors. Cancer Res 64: 9139-9143, 2004. (Pubitemid 39665528)
28. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE and Meyerson M: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497-1500, 2004. (Pubitemid 38720929)
29. Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II, Fong KM, Lee H, Toyooka S, Shimizu N, Fujisawa T, Feng Z, Roth JA, Herz J, Minna JD and Gazdar AF: Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97: 339-346, 2005. (Pubitemid 40425952)
30. Armanios M and Greider CW: Telomerase and cancer stem cells. Cold Spring Harb Symp Quant Biol 70: 205-208, 2005. (Pubitemid 44124873)